A number of recent polls have suggested the Democrats are now leading Republicans in generic ballots for the upcoming midterm elections, with just two months to ... by 44.8 percent to 43.9 ...
Pros & Cons Earn up to 2% cash back—1% when the purchase is ... after you spend $1,500 in purchases with your card within 3 months of account opening; redeemable for $200 in gift cards at ...
A MOM has revealed how she was widowed with seven kids, then married a new man after just two months of dating him ... City told us that he had a grade 2 astrocytoma tumor with a survival rate ...
Gilead Sciences Inc's Trodelvy extended by 3.2 months the survival of patients with advanced stages of a common type of breast cancer, according to data released ahead of a presentation at a ...
Based on a newly submitted analysis, the survival benefit from the drug is in the range of 10.6 months to 18.8 months ... 93 per share, in Q2 compared to a net loss of $21.9 million, or $3. ...
China's stash of Treasurys rose to $970 billion in July, from $967.8 ... 2.904%, and ended the month at 2.642%. China increased its holdings of Treasurys in July for the first time in eight months ...
CNBC12d
Meanwhile, fuelling concerns about a slowing economy, the Index of Industrial Production (IIP) which measures industrial growth, crashed from 12.3 per cent in June to 2.4 per cent in ... the RBI’s ...
Five consecutive months of decline in the new car market was halted in August, new figures show. Registrations of new cars increased by 1.2% last month ... so far are 35.3% down on the same ...
Sept 7 (Reuters) - Gilead Sciences Inc's (GILD.O) Trodelvy extended by 3.2 months the survival of patients with advanced stages of a common type of breast cancer, according to data released ahead ...
(Reuters) - Gilead Sciences Inc's Trodelvy extended by 3.2 months the survival of patients with advanced stages of a common type of breast cancer, according to data released ahead of a presentation at ...